About
Nkarta Inc (NASDAQ:NKTX) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 15 2026
Nkarta Announces FDA Agreement on Outpatient Dosing of NKX019 in Autoimmune Disease, Expanding Access to Community Rheumatology Centers
Apr 9 2026
Nkarta to Participate in Needham Virtual Healthcare Conference
Mar 25 2026
Nkarta Reports Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights
Dec 2 2025
Nkarta to Participate in Evercore Healthcare Conference
Nov 10 2025
Nkarta Reports Third Quarter 2025 Financial Results and Corporate Highlights
Financials
Revenue
$385
Market Cap
$168.25 M
EPS
-1.41
Translate